Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and renal outcomes: prevalent user designs may overestimate benefit.

Laurie Tomlinson ORCID logo; Liam Smeeth ORCID logo; (2014) Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and renal outcomes: prevalent user designs may overestimate benefit. JAMA internal medicine, 174 (10). 1706-. ISSN 2168-6106 DOI: 10.1001/jamainternmed.2014.1585
Copy

picture_as_pdf
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and Renal Outcomes_GOLD VoR.pdf
subject
Published Version
copyright
Available under Copyright the publishers

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads